QR-Code

Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States

Several types of antibodies (Abs) are currently used in non-small cell lung cancer (NSCLC). Anti-angiogenic and immune checkpoint inhibitor (ICI) Abs are the most frequent treatments used alone or with chemotherapy in metastatic NSCLC, for the front line and beyond. Considering the many therapeutic...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Marion Ferreira, Thomas Secher, Nathalie Heuze-Vourc’H, Karen L Reckamp
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI AG 2021-06-01
Schriftenreihe:Pharmaceutics
Schlagworte:
lung cancer
immune checkpoint inhibitors
anti-angiogenic
antibodies
cancer treatment
Online-Zugang:https://www.mdpi.com/1999-4923/13/6/912
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge